Exane Derivatives’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
|
|||||
2022
Q1 | $811K | Buy |
|
|||||
2021
Q4 | – | Sell |
|
|||||
2021
Q3 | $186K | Buy |
|
|||||
2021
Q2 | $189K | Buy |
|
|||||
2021
Q1 | $157K | Buy |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $521K | Buy |
|
|||||
2020
Q2 | $469K | Sell |
|
|||||
2020
Q1 | $580K | Buy |
|
|||||
2019
Q4 | $11.7K | Sell |
|
|||||
2019
Q3 | $189K | Hold |
|
|||||
2019
Q2 | $205K | Buy |
|
|||||
2019
Q1 | $8.64K | Sell |
|
|||||
2018
Q4 | $133K | Hold |
|
|||||
2018
Q3 | $154K | Buy |
|
|||||
2018
Q2 | $119K | Hold |
|
|||||
2018
Q1 | $113K | Buy |
|
|||||
2017
Q4 | $150 | Hold |
|
|||||
2017
Q3 | $152 | Hold |
|
|||||
2017
Q2 | $129 | Sell |
|
|||||
2017
Q1 | $16.7K | Sell |
|
|||||
2016
Q4 | $112K | Buy |
|
|||||
2016
Q3 | $51.4K | Sell |
|
|||||
2016
Q2 | $374K | Buy |
|
|||||
2016
Q1 | $317K | Buy |
|
|||||
2015
Q4 | $86.2K | Buy |
|
|||||
2015
Q2 | – | Sell |
|
|||||
2015
Q1 | $187K | Sell |
|
|||||
2014
Q4 | $23.6M | Buy |
|